Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Cash from Operations (2016 - 2025)

iBio (IBIO) has disclosed Cash from Operations for 16 consecutive years, with 5235000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 35.31% to 5235000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 18616000.0 through Dec 2025, down 15.36% year-over-year, with the annual reading at 15300000.0 for FY2025, 17.74% up from the prior year.
  • Cash from Operations for Q4 2025 was 5235000.0 at iBio, up from 5665000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 3116000.0 in Q1 2025, with the low at 13959000.0 in Q3 2022.
  • Average Cash from Operations over 5 years is 6364550.0, with a median of 5287500.0 recorded in 2023.
  • The sharpest move saw Cash from Operations crashed 94.11% in 2021, then skyrocketed 61.75% in 2023.
  • Over 5 years, Cash from Operations stood at 10686000.0 in 2021, then grew by 28.55% to 7635000.0 in 2022, then soared by 38.36% to 4706000.0 in 2023, then rose by 17.79% to 3869000.0 in 2024, then crashed by 35.31% to 5235000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 5235000.0, 5665000.0, and 4600000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.